SCHEMBL6072469

SCHEMBL6072469

CC(=O)Nc1ccccc1-c1ccc2c(c1)Oc1ccccc1C2C1CCN(c2ccccn2)C(C)C1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ATR Q13535 2/20 0.36
ATRIP Q8WXE1 1/20 0.36
ALDH1A1 P00352 2/20 0.36
KDM4E B2RXH2 1/20 0.36
LMNA P02545 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2C9 P11712 1/20 0.36
HPGD P15428 1/20 0.36
MAPK1 P28482 1/20 0.36
CYP2C19 P33261 1/20 0.36
HTT P42858 1/20 0.36
HSD17B10 Q99714 1/20 0.36
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
SYK P43405 10/20 0.35
CDK5 Q00535 2/20 0.34
CDK5R1 Q15078 2/20 0.34
DYRK1A Q13627 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5090965 0.82 KDM4E (0.42) ALDH1A1KDM4ECYP2D6MAPK1CYP2C19
SCHEMBL4520693 0.79 OPRM1 (0.40) HRH3
SCHEMBL6072472 0.79 DHODH (0.36) ALDH1A1LMNACYP1A2CYP3A4CYP2C9
SCHEMBL5091903 0.77 MEN1 (0.37) MEN1KMT2A
SCHEMBL4518086 0.77 DHODH (0.38) ALDH1A1KDM4EHTTMEN1KMT2A
SCHEMBL27687176 0.77 TRPV1 (0.38) ALDH1A1MEN1KMT2AHRH3
SCHEMBL5094846 0.77 CHRM1 (0.42) ALDH1A1KDM4EHTTMEN1KMT2A
SCHEMBL5094817 0.76 MEN1 (0.37) ALDH1A1MEN1KMT2A
SCHEMBL5096927 0.76 SIGMAR1 (0.44) ALDH1A1MEN1KMT2A
SCHEMBL5097413 0.75 MCHR1 (0.40) ALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060135522-A1 Tricyclic delta-opioid modulators CARSON JOHN R 2006-06-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060135522-A1 Tricyclic delta-opioid modulators OPRD1, OPRK1, OPRL1 ATR 4799/4885ATRIP 4400/4885ALDH1A1 1302/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.